1α,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action

Endocrine Regulations

Volumn 38, Issue 1, 2004, Pages 29-38

  Nezbedova, P ^a   Brtko, Julius ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

Gene expression; Mechanism of action; Nuclear receptors; Vitamin D3

Indexed keywords

ANDROGEN RECEPTOR; CALCITRIOL; CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; LIGAND; PROGESTERONE RECEPTOR; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; VITAMIN D; VITAMIN D RECEPTOR; 2 METHYL 1,25 DIHYDROXYVITAMIN D3; 2-METHYL-1,25-DIHYDROXYVITAMIN D3; CALCITRIOL RECEPTOR; CELL RECEPTOR; DRUG DERIVATIVE;

AMINO ACID SEQUENCE; BONE; CALCIUM HOMEOSTASIS; CANCER CHEMOTHERAPY; CANCER PREVENTION; CHEMOPROPHYLAXIS; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; INTESTINE; KIDNEY; PROTEIN PROCESSING; REVIEW; SEQUENCE HOMOLOGY; VITAMIN D RESPONSIVE ELEMENT; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NEOPLASM;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; NEOPLASMS; RECEPTORS, CALCITRIOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; VITAMIN D;

EID: 4043083551     PISSN: 12100668     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. BAKER AR, MCDONNELL DP, HUGHES M et al.: Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85, 3294-3298, 1988
2. BAUDINO TA, KRAICHELY DM, JEFCOAT SC, Jr et al.: Isolation and characterization of a novel coactivator protein, NCoA-62, involved in vitamin D-mediated transcription. J Biol Chem 273, 16434-16441, 1998
3. BHATTACHARJEE M, WIENTROUB S, VONDERHAAR BK: Milk protein synthesis by mammary glands of vitamin D-deficient mice. Endocrinology 121, 865-874, 1987
4. BIKLE DD, PILLAI S: Vitamin D, calcium, and epidermal differentiation. Endocr Rev 14, 3-19, 1993
5. BRTKO J, THALHAMER J: Renaissance of the biologically active vitamin a derivatives: established and novel directed therapies for cancer and chemoprevention. Curr Pharm Des 9, 2067-2077, 2003
6. CARLBERG C: Molecular basis of the selective activity of vitamin D analogues. J Cell Biochem 88, 274-281, 2003
7. CHEN H, LIN RJ, SCHILTZ RL et al.: Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90, 569-580, 1997
8. CHOI M, YAMAMOTO K, ITOH T et al.: Interaction between vitamin D receptor and vitamin D ligands. Two-dimensional alanine scanning mutational analysis. Chem Biol 10, 261-270, 2003
9. CHRISTAKOS S, RAVAL-PANDYA M, WERNYJ RP et al.: Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3. Biochem J 316, 361-371, 1996
10. CLEMENS TL, ADAMS JS, HENDERSON SL et al.: Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1, 74-76, 1982
11. CORDER EH, GUESS HA, HULKA BS et al.: Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 2, 467-472, 1993
12. CROSS HS, PETERLIK M, REDDY GS et al.: Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alpha-hydroxylase activity and regulation of side-chain metabolism. J Steroid Biochem Mol Biol 62, 21-28, 1997
13. DARWISH H, DELUCA HF: Vitamin D-regulated gene expression. Crit Rev Eukaryot Gene Expr 3, 89-116, 1993
14. DARWISH HM, DELUCA HF: Recent advances in the molecular biology of vitamin D action. Prog Nucleic Acid Res Mol Biol 53, 321-344, 1996
15. DUSSO AS, NEGREA L, GUNAWARDHANA S et al.: On the mechanisms for the selective action of vitamin D analogs. Endocrinology 128, 1687-1692, 1991
16. EISMAN JA, KOGA M, SUTHERLAND RL et al.: 1,25-Dihydroxyvitamin D3 and the regulation of human cancer cell replication. Proc Soc Exp Biol Med 191, 221-226, 1989
17. EISMAN JA, SUVA LJ, MARTIN TJ: Significance of 1,25-dihydroxyvitamin D3 receptor in primary breast cancers. Cancer Res 46, 5406-5408, 1986
18. EISMAN JA, SUVA LJ, SHER E et al.: Frequency of 1,25-dihydroxyvitamin D3 receptor in human breast cancer. Cancer Res 41, 5121-5124, 1981
19. EVANS RM: The steroid and thyroid hormone receptor superfamily. Science 240, 889-895, 1988
20. FARACO JH, MORRISON NA, BAKER A et al.: ApaI dimorphism at the human vitamin D receptor gene locus. Nucleic Acids Res 17, 2150, 1989
21. FRAMPTON RJ, OMOND SA, EISMAN JA: Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites. Cancer Res 43, 4443-4447, 1983
22. FREEDMAN LP: Anatomy of the steroid receptor zinc finger region. Endocr Rev 13, 129-145, 1992
23. FREEDMAN LP, ARCE V, PEREZ-FERNANDEZ R: DNA sequences that act as high affinity targets for the vitamin D3 receptor in the absence of the retinoid X receptor. Mol Endocrinol 8, 265-273, 1994
24. GASCON-BARRE M, DEMERS C, MIRSHAHI A et al.: The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells. Hepatology 37, 1034-1042, 2003
25. GLASS CK: Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev 15, 391-407, 1994
26. GLENDENNIG P, RAJTACZAK T, PRINCE R et al.: The promoter region of the human PCMA I gene meiates transcriptional down regulation by 1,25dihydroxyvitamin D3. Biochem Biophys Res Commun 277, 722-728, 2000
27. GROSS C, ECCLESHALL TR, MALLOY PJ et al.: The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 11, 1850-1855, 1996
28. GUO B, ASLAM F, VAN WIJNEN AJ et al.: YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene. Proc Natl Acad Sci USA 94, 121-126, 1997
29. HADDAD JG, MATSUOKA LY, HOLLIS BW et al.: Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 91, 2552-2555, 1993
30. HARTWELL D, HASSAGER C, CHRISTIANSEN C: Effect of vitamin D2 and vitamin D3 on the serum concentrations of 1,25(OH)2D2, and 1,25(OH)2D3 in normal subjects. Acta Endocrinol (Copenh) 115, 378-384, 1987
31. HAUSSLER MR, NORMAN AW: Chromosomal receptor for a vitamin D metabolite. Proc Natl Acad Sci USA 62, 155-162, 1969
32. HAUSSLER MR, WHITFIELD GK, HAUSSLER CA et al.: The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13, 325-349, 1998
33. HOENDEROP JG, MULLER D, VAN DER KEMP AW et al.: Calcitriol controls the epithelial calcium channel in kidney. J Am Soc Nephrol 12, 1342-1349, 2001
34. HOLICK MF: Vitamin D: A millenium perspective. J Cell Biochem 88, 296-307, 2003
35. HONG H, KOHLI K, GARABEDIAN MJ et al.: GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17, 2735-2744, 1997
36. HSIEH JC, SHIMIZU Y, MINOSHIMA S et al.: Novel nuclear localization signal between the two DNA-binding zinc fingers in the human vitamin D receptor. J Cell Biochem 70, 94-109, 1998
37. ISSA LL, LEONG GM, EISMAN JA: Molecular mechanism of vitamin D receptor action. Inflamm Res 47, 451-475, 1998
38. JOHNSON CS, HERSHBERGER PA, BERNARDI RJ et al.: Vitamin D receptor: a potential target for intervention. Urology 60, 123-130; discussion 130-131, 2002
39. JURUTKA PW, HSIEH JC, REMUS LS Et al.: Mutations in the 1,25-dihydroxyvitamin D3 receptor identifying C- terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription factor IIB, in vitro. J Biol Chem 272, 14592-14599, 1997
40. JURUTKA PW, REMUS LS, WHITFIELD GK et al.: The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 14, 401-420, 2000
41. KRISHNAN A, FELDMAN D: Regulation of vitamin D receptor abundance. In: Feldman d, Glorieux FH, Pike JW: Vitamin D, Academic Press, New York 179-200, 1997
42. KRISTAL-BONEH E, FROOM P, HARARI G et al.: Association of calcitriol and blood pressure in normotensive men. Hypertension 30, 1289-1294, 1997
43. LE DOUARIN B, ZECHEL C, GARNIER JM et al.: The N-terminal part of TIF1, a putative mediator of the ligand- dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. Embo J 14, 2020-2033, 1995
44. LEMIRE JM, ARCHER DC: 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87, 1103-1107, 1991
45. LI YC, KONG J, WEI M et al.: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110, 229-238, 2002
46. LIND L, HANNI A, LITHELL H et al.: Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 8, 894-901, 1995
47. MACLAUGHLIN J, HOLICK MF: Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76, 1536-1538, 1985
48. MALLOY PJ, FELDMAN D: Vitamin D resistance. Am J Med 106, 355-370, 1999
49. MANGELSDORF DJ, EVANS RM: The RXR heterodimers and orphan receptors. Cell 83, 841-850, 1995
50. MANGELSDORF DJ, THUMMEL C, BEATO M et al.: The nuclear receptor superfamily: the second decade. Cell 83, 835-839, 1995
51. MANOLAGAS SC, PROVVEDINI DM, TSOUKAS CD: Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol 43, 113-122, 1985
52. MASUYAMA H, BROWNFIELD CM, ST-ARNAUD R et al.: Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol Endocrinol 11, 1507-1517, 1997
53. MEEHAN TF, DELUCA HF: The vitamin D receptor is necessary for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Arch Biochem Biophys 408, 200-204, 2002
54. MEHTA RG, MEHTA RR: Vitamin D and cancer. J Nutr Biochem 13, 252-264, 2002
55. MELLANBY E: Nutrition Classics. The Lancet 1:407-12, 1919. An experimental investigation of rickets. Edward Mellanby. Nutr Rev 34, 338-340, 1976.
56. MELLANBY E: Nutrition Classics. The Lancet 1:407-12, 1919. An experimental investigation of rickets. Edward Mellanby. Nutr Rev 34, 338-340, 1976.
57. MEZZETTI G, MONTI MG, CASOLO LP et al.: 1,25-Dihydroxycholecalciferol- dependent calcium uptake by mouse mammary gland in culture. Endocrinology 122, 389-394, 1988
58. MIYAMOTO K, KESTERSON RA, YAMAMOTO H et al.: Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol 11, 1165-1179, 1997
59. MOHR SC, SWAMY N, XU W et al.: Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1alpha,25- dihydroxyvitamin D(3) receptor? Steroids 66, 189-201, 2001
60. NAKAJIMA S, YANAGIHARA I, OZONO K: A 65-kilodalton nuclear protein binds to the human vitamin D receptor: a bacterial-expressed histidine-tagged receptor study. Biochem Biophys Res Commun 232, 806-809, 1997
61. NORMAN AW: Receptors for 1alpha,25(OH)2D3: past, present, and future. J Bone Miner Res 13, 1360-1369, 1998
62. NORMAN AW, OLIVERA CJ, BARRETO-SILVA FR et al.: A specific binding protein/receptor for 1alpha,25-dihydroxyvitamin D(3) is present in an intestinal caveolae membrane fraction. Biochem Biophys Res Commun 298, 414-419, 2002
63. PINETTE KV, YEE YK, AMEGADZIE BY et al.: Vitamin D receptor as a drug discovery target. Mini Rev Med Chem 3, 193-204, 2003
64. RACHEZ C, LEMON BD, SULDAN Z et al.: Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398, 824-828, 1999
65. REICHEL H, KOEFFLER HP, NORMAN AW: The role of the vitamin D endocrine system in health and disease. N Engl J Med 320, 980-991, 1989
66. SEMMLER EJHM, SCHNOES HK, DELUCA HF: The synthesis of 1α,25-dihydroxycholecalciferol: A metabolically active form of vitamin D3. Tetrahedron Lett 40, 4147-4150, 1972
67. SCHRADER M, MULLER KM, CARLBERG C: Specificity and flexibility of vitamin D signaling. Modulation of the activation of natural vitamin D response elements by thyroid hormone. J Biol Chem 269, 5501-5504, 1994
68. SCHWARTZ GG, HULKA BS: Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 10, 1307-1311, 1990
69. SCHWARTZ GG, WHITLATCH LW, CHEN TC et al.: Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 7, 391-395, 1998
70. SILBERSTEIN GB: Postnatal mammary gland morphogenesis. Microsc Res Tech 52, 155-162, 2001
71. SIMBOLI-CAMPBELL M, NARVAEZ CJ, TENNISWOOD M et al.: 1,25- Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 58, 367-376, 1996
72. SIMBOLI-CAMPBELL M, NARVAEZ CJ, VAN WEELDEN K et al.: Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. Breast Cancer Res Treat 42, 31-41, 1997
73. SOLOMON C, MACORITTO M, GAO XL et al.: The unique tryptophan residue of the vitamin D receptor is critical for ligand binding and transcriptional activation. J Bone Miner Res 16, 39-45, 2001
74. SONE T, KERNER S, PIKE JW: Vitamin D receptor interaction with specific DNA. Association as a 1,25-dihydroxyvitamin D3-modulated heterodimer. J Biol Chem 266, 23296-23305, 1991
75. STRUGNELL SA, HILL JJ, MCCASLIN DR et al.: Bacterial expression and characterization of the ligand-binding domain of the vitamin D receptor. Arch Biochem Biophys 364, 42-52, 1999
76. SUTTON AL, MACDONALD PN: Vitamin D: More Than a "Bone-a-Fide" Hormone. Mol Endocrinol 17, 777-791, 2003
77. SZPIRER J, SZPIRER C, RIVIERE M et al.: The Sp1 transcription factor gene (SP1) and the 1,25-dihydroxyvitamin D3 receptor gene (VDR) are colocalized on human chromosome arm 12q and rat chromosome 7. Genomics 11, 168-173, 1991
78. TAKETANI Y, SEGAWA H, CHIKAMORI M et al.: Regulation of type II renal Na+-dependent inorganic phosphate transporters by 1,25-dihydroxyvitamin D3. Identification of a vitamin D-responsive element in the human NAPi-3 gene. J Biol Chem 273, 14575-14581, 1998
79. TIAN XQ, CHEN TC, MATSUOKA LY et al.: Kinetic and thermodynamic studies of the conversion of previtamin D3 to vitamin D3 in human skin. J Biol Chem 268, 14888-14892, 1993
80. UMESONO K, MURAKAMI KK, THOMPSON CC et al.: Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65, 1255-1266, 1991
81. USHEVA A, SHENK T: TATA-binding protein-independent initiation: YY1, TFIIB, and RNA polymerase II direct basal transcription on supercoiled template DNA. Cell 76, 1115-1121, 1994
82. WEIGEL NL: Steroid hormone receptors and their regulation by phosphorylation. Biochem J 319, 657-667, 1996
83. WELSH J, WIETZKE JA, ZINSER GM et al.: Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer. J Steroid Biochem Mol Biol 83, 85-92, 2002
84. WIETZKE JA, WELSH J: Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells. J Steroid Biochem Mol Biol 84, 149-157, 2003
85. WIKVALL K: Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review). Int J Mol Med 7, 201-209, 2001
86. WOOD RJ, FLEET JC: The genetics of osteoporosis: vitamin D receptor polymorphisms. Annu Rev Nutr 18, 233-258, 1998
87. WURTZ JM, BOURGUET W, RENAUD JP et al.: A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 3, 206, 1996
88. YAMADA S, YAMAMOTO K, MASUNO H: Structure-function analysis of vitamin D and VDR model. Curr Pharm Des 6, 733-748, 2000
89. YANAGI Y, SUZAWA M, KAWABATA M et al.: Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins. J Biol Chem 274, 12971-12974, 1999
90. YANAGISAWA J, YANAGI Y, MASUHIRO Y et al.: Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283, 1317-1321, 1999
91. YUAN CX, ITO M, FONDELL JD et al.: The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc Natl Acad Sci USA 95, 7939-7944, 1998
92. ZINSER G, PACKMAN K, WELSH J: Vitamin D(3) receptor ablation alters mammary gland morphogenesis. Development 129, 3067-3076, 2002